Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
A Phase 1b Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: March 27, 2026
Delayed fatal neurotoxicity in post CAR-T cell therapy for multiple myeloma, a case report.
Journal: Leukemia research reports
Published: August 20, 2025
A phase 1b study on the safety of Wharton's jelly mesenchymal stromal cells in the treatment of acute graft-versus-host disease.
Journal: Cytotherapy
Published: August 14, 2025
Advances in stem cell and cellular therapeutics from the 9th Midwest Conference on Cell Therapy and Regenerative Medicine.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 14, 2025
Large Scale Manufacturing of Wharton's Jelly Mesenchymal Stromal Cells for Clinical Use.
Journal: Stem cells international
Published: May 15, 2025
Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma.
Journal: Future oncology (London, England)
Published: May 09, 2025
Large-scale manufacturing of immunosuppressive extracellular vesicles for human clinical trials.
Journal: Cytotherapy
Published: December 10, 2024
Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis.
Journal: Hematology, transfusion and cell therapy
Published: October 03, 2024
Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 19, 2024
Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic review.
Journal: Transplant immunology
Published: June 04, 2024
Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell transplantation.
Journal: Hematology, transfusion and cell therapy
Published: May 26, 2024
Successful Use of a Midline Catheter for Leukapheresis in Patients Undergoing Collection for Immune Effector Cell Therapy, Donor Lymphocyte Infusion, and Hematopoietic Progenitor Cell Collection.
Journal: Journal of clinical apheresis
Published: April 01, 2024
Last Updated: 09/26/2026